About SensOmics
SensOmics is a company based in Toronto (Canada) founded in 2007. SensOmics offers products and services including SensWatch BP, SensWatch R, and Data Platform. SensOmics operates in a competitive market with competitors including MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others.
- Headquarter Toronto, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Asset Management Ventures
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SensOmics
SensOmics offers a comprehensive portfolio of products and services, including SensWatch BP, SensWatch R, and Data Platform.
Monitors blood pressure continuously for accurate health tracking.
Tracks physiological parameters in real-time for advanced monitoring.
Analyzes health data using AI for insights and alerts.
Funding Insights of SensOmics
Investors in SensOmics
SensOmics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Asset Management Ventures and iSeed Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage US companies are invested in by Asset Management Ventures.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in AI and digital health startups based in San Francisco.
|
Locked | Locked | Locked |
Investor details for SensOmics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SensOmics
Investment portfolio details for SensOmics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SensOmics
Detailed financials for SensOmics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sensomics Comparisons
Peer comparison for SensOmics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SensOmics
SensOmics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Genetic testing products for health risks and traits are offered.
|
|
| Locked | Locked | Locked |
Personalized cancer diagnostics are developed using genomic big data analysis.
|
|
| Locked | Locked | Locked |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
Detailed competitors of SensOmics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sensomics
Complete news archive for SensOmics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SensOmics
SensOmics was founded in 2007 and raised its 1st funding round 10 years after it was founded.
SensOmics is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
SensOmics was founded in 2007 in Toronto, Canada, within the precision medicine sector. Childrens health is addressed through the integration of genomics, clinical informatics, and machine learning to analyze the human genome. A primary focus is placed on Autism, with operations centered on developing targeted health solutions. Services encompass data-driven insights for pediatric care in North America.
SensOmics's top competitors include Foundation Medicine, MedGenome and Personalis.
SensOmics offers SensWatch BP, SensWatch R, and Data Platform.
SensOmics has 2 investors. Key investors include Asset Management Ventures, and iSeed Ventures.